ConductScience.org, home

Library / Trials

Impact of Probiotic Supplementation on Cognition and Related Health Outcomes Among Video Gamers

NCT05545813, Phase 2, Completed, Lallemand Health Solutions

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleImpact of Probiotic Supplementation on Cognition and Related Health Outcomes Among Video GamersClinicalTrials.gov
NCT numberNCT05545813ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesPhase 2ClinicalTrials.gov
Enrollment36 participants, actualClinicalTrials.gov
Lead sponsorLallemand Health SolutionsClinicalTrials.gov
ConditionsStress, Attention DisturbancesClinicalTrials.gov
InterventionsProbiotic, PlaceboClinicalTrials.gov
First posted2022-09-19ClinicalTrials.gov
Last updated2023-11-29ClinicalTrials.gov

Registered outcomes 16

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryChange in reaction time8 weeks
The statistical difference in change in reaction time (in milliseconds) from baseline during a computerized task-switching color-word Stroop task following acute stress between the probiotic and placebo groups.
ClinicalTrials.gov
SecondaryChange in reaction time: acute stress condition8 weeksThe statistical difference in changes in reaction time (in milliseconds) on a computerized incongruent CWST between probiotic and placebo groups following acute stress.ClinicalTrials.gov
SecondaryChange in accuracy: acute stress condition8 weeksThe statistical difference in changes in accuracy (proportion correct) on a computerized task-switching CWST and incongruent CWST between probiotic and placebo groups following acute stress.ClinicalTrials.gov
SecondaryChange in reaction time: non-stressful condition8 weeks
The statistical difference in changes in reaction time (in milliseconds) on a computerized task-switching and incongruent CWST and a visual search (VS) paradigm, between probiotic and placebo groups in a non-stressful condition.
ClinicalTrials.gov
SecondaryChange in accuracy: non-stressful condition8 weeks
The statistical difference in changes in accuracy (proportion correct; %false alarms) on a computerized task-switching and an incongruent CWST, a go/no-go paradigm, a visual working memory maintenance paradigm, and a visual working memory complex span task (SYMSPAN) between probiotic and placebo groups in a non-stressful condition.
ClinicalTrials.gov
SecondaryChange in self-reported cognitive control: non-stressful condition8 weeks
The statistical difference in changes in self-reported cognitive control and cognitive flexibility as per the Cognitive Control and Flexibility Questionnaire (CCFQ) between probiotic and placebo groups in a non-stressful condition.
ClinicalTrials.gov
SecondaryChanges in oxyhemoglobin concentrations in pre-frontal cortex8 weeks
The statistical difference in changes in concentrations of oxygenated hemoglobin in the prefrontal cortex (PFC) during the task-switching CWST from baseline between the probiotic and placebo groups following acute stress and under non-stress conditions.
ClinicalTrials.gov
SecondaryChanges in cortisol8 weeks
The statistical difference in changes in the cortisol response to acute stress from baseline, as measured by the area under the curve with respect to increase (AUCi) and with respect to ground (AUCg) between probiotic and placebo groups.
ClinicalTrials.gov
SecondaryChanges in salivary DHEA-S8 weeksThe statistical difference in salivary DHEA-S from baseline between the probiotic and placebo groups.ClinicalTrials.gov
SecondaryChanges in salivary cortisol/DHEA-S ratio8 weeksThe statistical difference in the salivary cortisol/DHEA-S ratio from baseline between the probiotic and placebo groups.ClinicalTrials.gov
SecondaryChanges in immune activity markers8 weeksThe statistical difference in changes in salivary levels of proinflammatory cytokines, interleukin-1 beta, and interleukin-6 from baseline between probiotic and placebo groups.ClinicalTrials.gov
SecondaryChanges in self-reported levels of depression symptomology8 weeksThe statistical difference in changes in the depression subscale score of the Depression, Anxiety, and Stress Scale Short Form (DASS-21) from baseline between the probiotic and placebo groups.ClinicalTrials.gov
SecondaryChanges in self-reported levels of anxiety symptomology8 weeksThe statistical difference in changes in the anxiety subscale score of the Depression, Anxiety, and Stress Scale Short Form (DASS-21) from baseline between the probiotic and placebo groups.ClinicalTrials.gov
SecondaryChanges in self-reported levels of perceived stress symptomology8 weeksThe statistical difference in changes in the stress subscale score of the Depression, Anxiety, and Stress Scale Short Form (DASS-21) from baseline between the probiotic and placebo groups.ClinicalTrials.gov
SecondaryChanges in self-reported levels of anxiety, depression, and perceived stress symptomology8 weeksThe statistical difference in changes in the total scale score of the Depression, Anxiety, and Stress Scale Short Form (DASS-21) between the probiotic and placebo groups.ClinicalTrials.gov
SecondaryChanges in self-reported sleep quality8 weeksThe statistical differences in changes in total Pittsburgh Sleep Quality Index (PSQI) scores between the probiotic and placebo groups.ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 3

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Stroop Color-Word TestPrimary outcomeConductCognition
Task Switching TestPrimary outcomeConductCognition
Go/No-Go TaskSecondary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)